Blepharoplasty is the third most popular cosmetic procedure with more than 147,500 performed last year. Natural results and a more youthful facial appearance are easily achieved in experienced hands.
March 2013 posts
Facial rejuvenation, reversal of sun damage, and the creation of a natural and more youthful appearance.
Neurologists and neuroscience professionals this week from around the world gathered at the American Academy of Neurology (AAN) 65th Annual Meeting in San Diego. The Multiple Sclerosis Center at Swedish Neuroscience Institute was pleased to co-author a few research trials presented at the meeting:
Teriflunomide and pregnancy
Dr. Lily Jung-Henson, neurologist and Chief of Staff at Swedish Issaquah, spoke on behalf of a team of researchers about teriflunomide and a report on the safety of women who became pregnant on the medication. Teriflunomide is a once-daily, oral disease-modifying therapy (DMT) recently approved in the United States to treat relapsing multiple sclerosis. Clinical trials for teriflunomide took place among the many research studies for new treatments Swedish Neuroscience Institute offers patients with multiple sclerosis. (Read the full abstract here.)
Subset of a trial looking at endurance effects of Dalfampridine (AMPYRA®)
Dr. Angeli Mayadev, physical medicine and rehabilitation specialist at the MS Center, participated in this study of a medication to improve walking speed in people with MS. Dalfampridine -ER 10 mg twice daily significantly improved 6-minute walking distance compared to placebo. Dalfampridine 5 mg twice daily did not improve distance compared to placebo. Researchers also found that ....
Read about the most current information about Silicone Implants for Breast Augmentation.
New Cancer Center to Open April 1 at Swedish/Edmonds; Outpatient Facility to Provide Medical Oncology, Infusion Services Close to Home
Swedish Cancer Institute at Edmonds opens to the public at an April 17 ribbon-cutting ceremony on the Swedish/Edmonds campus. (Left to right) David Loud, aide from Congressman Jim McDermott, M.D.; Swedish Cancer Institute Medical Oncologist Richard McGee, M.D.; Swedish/Edmonds Chief Executive Dave Jaffe; and Swedish Cancer Institute Executive Director Thomas D. Brown, M.D., MBA, cut the ribbon during the event that attracted 250 visitors. The two-story facility, located at 21632 Highway 99 in Edmonds, provides high-quality and comprehensive medical oncology to patients through an infusion unit, laboratory, pharmacy, and access to Swedish’s electronic medical record system.
EDMONDS, WASH., March 21, 2013 – Swedish Health Services will open a new outpatient cancer center at the Edmonds campus on Monday, April 1, 2013 in response to the growing need for medical oncology and infusion (chemotherapy) services in the south Snohomish and north King County area. The new two-story, 17,102-square-foot facility is anticipated to handle as many as 175 patient visits each day and provide increased access to cancer-care services for people living north of Seattle.
Instead of only focusing on what patients need to do to improve their health, let's look at what they bring to a doctor’s appointment.
Here are 10 things that physicians love about their patients:
10. Their preparedness. One might think that doctors cringe when patients pull out “the list” of their concerns and questions. On the contrary: this adds great efficiency and still helps us to be complete in what we do. The last thing a doctor wants is for a patient to go home and worry about something they forgot to ask us.
9. Their self-discipline. I have seen many patients shed pounds, shake off cigarettes, trim down on alcohol consumption and put on those sneakers day after day. If I’m honest, I’d say that I myself exercise just so I can look these inspiring individuals in the eyes when we talk about fitness.
8. Their knowledge. I don’t always know the “latest and greatest” developments in medicine. My patients are well-informed, and not uncommonly alert me to something I need to research or bone up on. They are “iron sharpening iron.”
7. Their ...
A small pilot study from the University of Southern California suggests a pulse adrenocorticotropic hormone (ACTH) therapy could be effective in patients with breakthrough multiple sclerosis attacks while on beta-interferon. “Breakthrough” attacks that occur after starting a disease modifying therapy (DMT).
The study compared the safety and benefits of monthly pulse ACTH to monthly methylprednisone (MP) pulse in patients on beta-interferon. Over 15 months, researchers found that those treated with ACTH had fewer relapses and fewer psychiatric side effects. ACTH gel is currently used to treat MS relapses, but researchers note it may be able to alter the body’s immune responses beyond producing steroids.
As I discussed with the Medscape reporter, Megan Brooks, last week, the results of this study are ....